SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego biotech Evofem Inc. has raised $25 million in a Series D round.
Organovo Holdings Inc., the San Diego firm that “bioprints” three-dimensional human tissue, has appointed Craig Kussman as chief financial officer.
San Diego drugmaker Sorrento Therapeutics is launching a joint venture with South Korea’s CHA Biotech to develop an anti-cancer therapy. This is the latest in a string of joint ventures Sorrento has created in the last few months.
San Diego medical device maker DJO Global reported a bump to its net sales in the second quarter.
BIOTECH: LabCorp Buys Struggling Diagnostic Co.
San Diego’s Sequenom Inc., which has seen a string of losses in recent years, is being acquired by LabCorp, a giant in the diagnostics and lab testing industry, in a deal worth $371 million.
BIOTECH: ResMed’s Efforts In Informatics Pay Off As Company’s Value Climbs
ResMed Inc. is shoring up its position in the “internet of medical things,” funneling massive resources into its digital health portfolio and watching its stock climb as a result.
San Diego device maker ResMed Inc. reported a sizeable jump in revenue both for the company’s fourth quarter and its full 2016 fiscal year.
Medical device maker NuVasive Inc. reported a significant boost to the company’s sales and revenue for the second quarter, topping Wall Street’s expectations.
San Diego’s Sequenom Inc. is being acquired by LabCorp, a giant in the diagnostics and lab testing industry, in a deal worth $371 million.
San Diego’s medtech giant Illumina Inc. reported Tuesday that its second quarter revenue rose 11 percent.
Organovo Holdings Inc., the San Diego firm that “bioprints” three-dimensional human tissue, is moving its stock to the biotech-heavy Nasdaq exchange from the NYSE MKT.
San Diego biopharma Apricus Biosciences is expanding its exclusive distribution deal with Swiss firm Ferring Pharmaceuticals Inc. and terminating its deal with German drugmaker Sandoz.
Pharmaceutical giant Allergan Plc is backing out of its deal with San Diego-based Adamis Pharmceuticals Corp. to commercialize the firm’s epinephrine pre-filled syringe for the treatment of life-threatening allergic reactions (anaphylaxis).
Local digital health company AristaMD raised $11 million in a Series A financing, the company announced Friday.
The University of California, San Diego is opening an office in downtown Tokyo, where researchers will seek partnerships with Japan’s booming life science industry.